Methadone-associated QTc prolongation: A case report and review of the literature

Primary Care Companion to the Journal of Clinical Psychiatry

Volumn 10, Issue 6, 2008, Pages 470-476

  Abramson, David W ^a   Quinn, Davin K ^a,e   Stern, Theodore A ^b,c,d  

^a MCLEAN HOSPITAL   (United States)

^b Sim Group   (France)

^c HARVARD MEDICAL SCHOOL   (United States)

^d WiFiMed Holdings ^*

^e MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHADONE;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; FEMALE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LABORATORY TEST; QT PROLONGATION; REVIEW;

EID: 58149153122     PISSN: 15235998     EISSN: 1555211X     Source Type: Journal    
DOI: 10.4088/PCC.v10n0609     Document Type: Review

References (23)

1. Priori SG, Schwartz PJ, Napolitano C, et al. Risk stratification in the long-QT syndrome. N Engl J Med 2003;348:1866-1874
2. Pearson EC, Woolsey RL. QT prolongation and torsades de pointes among methadone users: reports to the FDA spontaneous reporting system. Pharmacoepidemiol Drug Saf 2005;14:747-753
3. Krantz MJ, Lewkowiez L, Hays H, et al. Torsades de pointes associated with very high dose methadone. Ann Intern Med 2002;137:501-504
4. Martell BA, Arnsten JH, Ray B, et al. The impact of methadone induction on cardiac conduction in opiate users. Ann Intern Med 2003;139(2):154-156
5. Martell BA, Arnsten JH, Krantz MJ, et al. Impact of methadone treatment on cardiac repolarization and conduction in opioid users. Am J Cardiol 2005;95:915-918
6. Krantz MJ, Lowery CM, Martell BA, et al. Effects of methadone on QT-interval dispersion. Pharmacotherapy 2005;25:1523-1529
7. Cruciani RA, Sekine R, Homel P, et al. Measurement of QTc in patients receiving chronic methadone therapy. J Pain Symptom Manage 2005;29:385-391
8. Ehret GB, Voide C, Gex-Fabry M, et al. Drug-induced long QT syndrome in injection drug users receiving methadone: high frequency in hospitalized patients and risk factors. Arch Intern Med 2006;166:1280-1287
9. Fanoe S, Hvidt C, Ege P, et al. Syncope and QT prolongation among patients treated with methadone for heroin dependence in the city of Copenhagen. Heart 2007;93(9):1051-1055
10. Katchman AN, McGroary KA, Kilborn MJ, et al. Influence of opioid agonists on cardiac human ether-a-go-go-related gene K(+) currents. J Pharmacol Exp Ther 2002 Nov;303(2):688-694
11. Gupta A, Lawrence AT, Krishnan K, et al. Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes. Am Heart J 2007;153(6):891-899
12. Magnano AR, Talathoti NB, Hallur R, et al. Effect of acute cocaine administration on the QTc interval of habitual users. Am J Cardiol 2006 Apr;97(8):1244-1246
13. Arizona Center for Education and Research on Therapeutics. University of Arizona College of Pharmacy. Resources for Professionals. Torsades List: Drugs With a Risk of Torsades de Pointes. Available at: http://www.qtdrugs.org/ medical-pros/drug-lists/bycategory.cfm. Accessed August 8, 2008
14. Flockhart DA. Drug Interactions: Cytochrome P450 Drug Interaction Table. Indiana University School of Medicine; 2007. Available at: http://medicine. iupui.edu/flockhart/table.htm. Accessed August 8, 2008
15. Gil M, Sala M, Anguera I, et al. QT prolongation and torsades de pointes in patients infected with human immunodeficiency virus and treated with methadone. Am J Cardiol 2003;92:995-997
16. Deamer RL, Wilson DR, Clark DS, et al. Torsades de pointes associated with high dose levomethadyl acetate (ORLAAM). J Addict Dis 2001;20(4):7-14
17. Wedam EF, Bigelow GE, Johnson RE, et al. QT-interval effects of methadone, levomethadyl, and buprenorphine in a randomized trial. Arch Intern Med 2007;167(22):2469-2475
18. Kornick CA, Kilborn MJ, Santiago-Palma J, et al. QTc interval prolongation associated with intravenous methadone. Pain 2003;105(3):499-506
19. Fredheim OM, Borchgrevink PC, Hegrenaes L, et al. Opioid switching from morphine to methadone causes a minor but not clinically significant increase in QTc time: a prospective 9-month follow-up study. J Pain Symptom Manage 2006;32:180-185
20. Peles E, Gershon B, Kreek MJ, et al. Corrected-QT intervals as related to methadone dose and serum level in methadone maintenance treatment patients: a cross sectional study. Addiction 2007;102:289-300
21. Eap CB, Crettol S, Rougier JS, et al. Stereoselective block of hERG channel by (S)-methadone and QT interval prolongation in CYP2B6 slow metabolizers. Clin Pharmacol Ther 2007;81(5):719-728
22. Baker JR, Best AM, Pade PA, et al. Effect of buprenorphine and antiretroviral agents on the QT interval in opioid-dependent patients. Ann Pharmacother 2006;40(3):392-396
23. Patel AM, Singh JP, Ruskin JN. Role of implantable cardioverter- defibrillators in patients with methadone-induced long QT syndrome. Am J Cardiol 2008;101(2):209-211